SUPPLEMENTAL ONLINE MATERIALS Results
The altered expression of the snoRNAs and microRNAs adjacent to the AAV integration sites could be a generalized phenomenon related to the cell cycle status of the tumor cells rather than a direct result of the integrated provirus. We believe that this is unlikely. There is a region on mouse chromosome 7 that contains >50 identified or predicted snoRNAs and microRNAs, which is syntenic with the human locus on chromosome 15 associated with Prader Willi /Angelman Syndrome, and is very similar to the locus containing vector proviruses in our study. These snoRNAs and microRNAs are between the ubiquitin-protein-ligase E3A (Ube3a) and the small-nuclearribonucleoprotein-N (Snrpn) genes and are thought to be expressed from a common transcript (Supplemental References 1, 2). Twelve primer sets assayed on the microarrays were present in this locus and none were significantly over expressed (expression levels were -22 to +1.6 fold changed in the tumor samples). The Snrpn transcript that encompasses the snoRNAs and microRNAs was changed -3 and -5 fold based on two separate primer sets. Thus there is not a generalized increase in the expression of snoRNAs or microRNAs in the tumor samples, and the 10 to >100-fold increased expression of the small RNA-containing transcripts on chromosome 12 can be explained by the presence of cis-acting elements within the integrated proviral sequences.
Methods
Animals. MPS VII and normal mice were produced by breeding B6.C-H-2 bm1 /ByBirgus mps /+ mice and were identified by GUSB assays and PCR. The transgenic animals are on the same genetic background as the experimental animals and have been described 
